Vaccine Delivery Devices Market Growth & Trends
The global vaccine delivery devices market size is anticipated to reach USD 11.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 7.6% from 2025 to 2030. The market is primarily driven by growing immunization programs, financial support from government and non-government organizations, increasing vaccination initiatives and campaigns, and the rising prevalence of infectious diseases globally. Growing research in the field of vaccines and the development of new products are also contributing to the growth of the market.
The adoption of a needle-free approach for administering these products is gaining momentum due to the growing awareness and demand to avoid pain and injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling the market growth. The rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.
The Covid-19 epidemic significantly boosted the market growth, especially due to the increasing demand for vaccination to tackle the spread of the virus. Increasing investment in Research & Development by vaccination device manufacturers as well as the governments has expanded the market significantly at an accelerated pace. Initiatives are undertaken by various regulatory authorities like UNICEF, Gavi, and WHO are also expected to boost the market growth.
Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the U.K. government also announced funding of up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and the WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.
Request a free sample copy or view the report summary: Vaccine Delivery Devices Market Report
Vaccine Delivery Devices Market Report Highlights
- By device, the syringes segment held the largest revenue share in 2024 due to the increasing vaccination programs, spreading immunization coverage, and technological advancements
- By route of administration, intradermal vaccination dominated the market in 2024 as the majority of vaccines are given through this route owing to its advantages
- North America dominated the global market in 2024 owing to the increasing awareness levels, high adoption of technology, and the rising prevalence of infectious diseases
Access Press Release@ https://www.grandviewresearch.com/press-release/global-vaccine-delivery-devices-market
Vaccine Delivery Devices Market Segmentation
Grand View Research has segmented the global vaccine delivery devices market report on the basis of device, route of administration, and region:
Vaccine Delivery Devices Device Outlook (Revenue, USD Million, 2018 - 2030)
- Syringes
- Jet Injectors
- Other Devices
Vaccine Delivery Devices Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Intradermal Vaccination
- Intramuscular Vaccination
- Subcutaneous Vaccination
- Other Vaccinations
Vaccine Delivery Devices Region Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- US.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List Of Key Players in the Vaccine Delivery Devices Market
- Becton Dickinson & Company
- Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
- PharmaJet
- Vaxxas
- Gerresheimer AG
- SCHOTT AG
- Corium International, Inc.
- 3M
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment